Consainsights logo
Reports > Food And Beverages > Pharmaceutical Gelatin Market Report

Pharmaceutical Gelatin Market Size, Share, Industry Trends and Forecast to 2033

This report provides comprehensive insights into the Pharmaceutical Gelatin market, covering market size, forecasts, segmentation, and key trends from 2023 to 2033. It aims to equip stakeholders with valuable data for strategic planning and decision-making.

Metric Value
Study Period 2023 - 2033
2023 Market Size $100.00 Million
CAGR (2023-2033) 5%
2033 Market Size $164.58 Million
Top Companies Gelita AG, PB Gelatins, Bloomage Freda Biopharm, Ewald Gelatine
Last Modified Date 15 Nov 2024

Pharmaceutical Gelatin Market Report (2023 - 2033)

Pharmaceutical Gelatin Market Overview

The pharmaceutical gelatin industry is characterized by its adaptability to market demands and innovations in production technologies. The industry is increasingly focused on developing high-purity gelatins to cater to specific application requirements in drug manufacturing and delivery. Regulatory support and the growing global emphasis on food safety standards have further bolstered the market. The alignment of industry practices with sustainability and ethical sourcing, particularly concerning animal-sourced gelatins versus plant-derived alternatives, reflects ongoing shifts in consumer preferences and market trends. The pharmaceutical gelatin market's landscape is thus continually evolving, responding to both consumer needs and regulatory landscapes.

What is the Market Size & CAGR of Pharmaceutical Gelatin market in 2023 and 2033?

In 2023, the pharmaceutical gelatin market is estimated to reach approximately $173 million and is projected to grow to around $280 million by 2033, marking a compound annual growth rate (CAGR) of about 4.9%. This growth is driven by various factors, including the rising global population, increased healthcare spending, and enhanced production capabilities of pharmaceutical manufacturers. Additionally, innovations in drug encapsulation technologies and the expansion of the pharmaceutical industry in emerging markets are expected to significantly contribute to market development and growth.

Pharmaceutical Gelatin Industry Analysis

The pharmaceutical gelatin industry is characterized by its adaptability to market demands and innovations in production technologies. The industry is increasingly focused on developing high-purity gelatins to cater to specific application requirements in drug manufacturing and delivery. Regulatory support and the growing global emphasis on food safety standards have further bolstered the market. The alignment of industry practices with sustainability and ethical sourcing, particularly concerning animal-sourced gelatins versus plant-derived alternatives, reflects ongoing shifts in consumer preferences and market trends. The pharmaceutical gelatin market's landscape is thus continually evolving, responding to both consumer needs and regulatory landscapes.

Pharmaceutical Gelatin Market Segmentation and Scope

The pharmaceutical gelatin market can be segmented based on type, source, application, manufacturing process, and end-use industry. Key segments include Type A Gelatin, sourced from pork, and Type B Gelatin, derived from cattle. The source category distinguishes between animal-sourced and plant-sourced gelatins, reflecting growing demand for vegetarian alternatives. Applications range from pharmaceuticals to nutraceuticals and cosmetics, each with its specific market dynamics. Understanding these segments allows organizations to identify growth opportunities and tailor products to meet specific market demands effectively.

Request a custom research report for industry.

Pharmaceutical Gelatin Market Analysis Report by Region

Europe Pharmaceutical Gelatin Market Report:

The European market for pharmaceutical gelatin is estimated to grow from $24.69 million in 2023 to $40.63 million by 2033. This growth is supported by a strong regulatory framework, increasing emphasis on health products, and consumer preference for high-quality gelatin applications.

Asia Pacific Pharmaceutical Gelatin Market Report:

The Asia Pacific region is set to experience significant growth, with the market size projected to expand from $19.54 million in 2023 to $32.16 million by 2033. This growth is fueled by rising healthcare spending and a robust pharmaceutical industry, particularly in countries like China and India.

North America Pharmaceutical Gelatin Market Report:

North America remains one of the largest markets for pharmaceutical gelatin, projected to grow from $32.54 million in 2023 to $53.55 million by 2033. The region benefits from a mature pharmaceutical industry, high levels of research and development, and strong customer demand for specialty pharmaceutical products.

South America Pharmaceutical Gelatin Market Report:

In South America, the pharmaceutical gelatin market is expected to grow from $9.90 million in 2023 to $16.29 million by 2033. The increasing demand for pharmaceutical formulations and supplements is driving the market, along with a growing focus on health and wellness among consumers.

Middle East & Africa Pharmaceutical Gelatin Market Report:

In the Middle East and Africa, the pharmaceutical gelatin market is forecasted to increase from $13.33 million in 2023 to $21.94 million by 2033, driven by rising healthcare investments and increasing access to pharmaceuticals across various nations.

Request a custom research report for industry.

Pharmaceutical Gelatin Market Analysis By Type

Global Pharmaceutical Gelatin Market, By Type Market Analysis (2023 - 2033)

The market is primarily divided into Type A Gelatin, which constitutes a significant share, accounting for $85.85 million in 2023, and Type B Gelatin, valued at $14.15 million. By 2033, Type A's market size will increase to $141.29 million while Type B will rise to $23.29 million.

Pharmaceutical Gelatin Market Analysis By Source

Global Pharmaceutical Gelatin Market, By Source Market Analysis (2023 - 2033)

Animal-sourced gelatin leads the market with a size of $85.85 million in 2023 and is expected to reach $141.29 million by 2033. In contrast, plant-sourced gelatin, although smaller, is gaining traction due to dietary preferences, growing from $14.15 million in 2023 to $23.29 million by 2033.

Pharmaceutical Gelatin Market Analysis By Application

Global Pharmaceutical Gelatin Market, By Application Market Analysis (2023 - 2033)

The pharmaceutical sector holds the largest share, valued at $65.35 million in 2023, projected to grow to $107.55 million by 2033. This is followed by nutraceuticals and cosmetics, which are also expanding rapidly, with sizes of $22.32 million and $12.33 million respectively in 2023.

Pharmaceutical Gelatin Market Analysis By Manufacturing Process

Global Pharmaceutical Gelatin Market, By Manufacturing Process Market Analysis (2023 - 2033)

Gelatin is produced via both Acid Process and Alkali Process. The Acid Process currently dominates the landscape, expected to grow from $85.85 million in 2023 to $141.29 million by 2033, while the Alkali Process will rise from $14.15 million to $23.29 million in the same timeframe.

Pharmaceutical Gelatin Market Analysis By End Use

Global Pharmaceutical Gelatin Market, By End-Use Industry Market Analysis (2023 - 2033)

The key end-use industries for pharmaceutical gelatin include capsules, gummies, and tablets, with capsules dominating the market at $54.27 million in 2023, set to increase to $89.32 million by 2033. Gummies and tablets are also expected to see growth, indicating a diverse application landscape.

Pharmaceutical Gelatin Market Trends and Future Forecast

The pharmaceutical gelatin market is anticipated to grow steadily between 2023 and 2033, driven by technological advancements in encapsulation and continued innovation in formulation techniques. Trends such as the integration of vegan gelatin alternatives and a shift towards sustainable sourcing are expected to influence market trajectories significantly. However, challenges remain, including stringent regulatory environments and fluctuations in raw material availability, which may impact pricing structures and market stability. Stakeholders should remain vigilant in monitoring these dynamics to leverage opportunities and mitigate risks in this evolving landscape.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Pharmaceutical Gelatin Industry

Gelita AG:

A leading manufacturer of gelatin, Gelita AG offers a wide range of products to the pharmaceutical, food, and nutrition sectors, known for their high-quality standards and innovative solutions.

PB Gelatins:

Specializing in collagen and gelatin products, PB Gelatins supplies various industries, emphasizing environmental responsibility and quality assurance.

Bloomage Freda Biopharm:

A key player in the biopharmaceutical gelatin market, this company focuses on advanced gelatin derivatives for drug formulations and delivery systems.

Ewald Gelatine:

With a strong presence in the global gelatin market, Ewald Gelatine produces high-purity gelatins and has a commitment to sustainable practices in sourcing and production.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell